Product Information
REMERON 30 MG TABLET is a brand product labeled by Organon LLC, priced at $6.6731 per EA under NDC 78206016101. Its NADAC has been published 94 times since Dec 18, 2024.
FDA first approved this application on Jun 14, 1996. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the MIRTAZAPINE market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
30 mg/1
Manufacturer
Organon LLCNDC
78206016101
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
1/1/2026
Active Ingredients
MIRTAZAPINEApproval Type
New Drug (NDA)
FDA Application
NDA020415FDA Approved
6/14/1996
TE Code
AB
On Market Since
6/1/2021
Price Statistics
The NADAC for REMERON 30 MG TABLET has been published 94 times since Dec 18, 2024, and over the history we have for it it has risen 9.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.6731 per EA |
|---|---|
| All-time high | $6.6731 (Sep 30, 2026) |
| All-time low | $6.0731 (Dec 18, 2024) |
| 52-week high | $6.6731 |
| 52-week low | $6.3434 |
| Median price | $6.3770 |
| Average price | $6.4899 |
| Largest weekly change | +5.0% (Jan 1, 2025) |
| Weeks tracked | 94 |
| Tracking since | Dec 18, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the MIRTAZAPINE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Organon LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
MIRTAZAPINE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of REMERON 30 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for REMERON 30 MG TABLET, manufactured by Organon LLC, is $6.6731 per EA (NDC 78206016101), effective Sep 30, 2026.
How has the price of REMERON 30 MG TABLET changed over time?
Over the history we have for it, the NADAC for REMERON 30 MG TABLET has risen 9.9%. It has been tracked across 94 weekly CMS publications since Dec 18, 2024.
What are the highest and lowest recorded NADAC prices for REMERON 30 MG TABLET?
Since Dec 18, 2024, the NADAC for REMERON 30 MG TABLET has ranged from a low of $6.0731 (Dec 18, 2024) to a high of $6.6731 (Sep 30, 2026), with a median of $6.3770 per EA.
Are there cheaper alternatives to REMERON 30 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of REMERON 30 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures REMERON 30 MG TABLET?
REMERON 30 MG TABLET (NDC 78206016101) is labeled by Organon LLC, and CMS classifies it as a brand product.